Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons

Author:

Righetto Germanna Lima12ORCID,Yin Yanting3ORCID,Duda David M3,Vu Victoria1,Szewczyk Magdalena M1,Zeng Hong1,Li Yanjun1,Loppnau Peter1,Mei Tony1,Li Yen-Yen1,Seitova Alma1,Patrick Aaron N4,Brazeau Jean-Francois5,Chaudhry Charu4,Barsyte-Lovejoy Dalia12ORCID,Santhakumar Vijayaratnam1ORCID,Halabelian Levon12ORCID

Affiliation:

1. Structural Genomics Consortium, University of Toronto , Toronto, Ontario M5G 1L7 , Canada

2. Department of Pharmacology and Toxicology, University of Toronto , Toronto, Ontario M5S 1A8 , Canada

3. Structural and Protein Sciences, Therapeutics Discovery, Janssen Research and Development , Spring House, PA 19044 , USA

4. Discovery Technology and Molecular Pharmacology, Therapeutics Discovery, Janssen Research and Development, LLC , Welsh and McKean Roads, Spring House, PA 19477 , USA

5. Discovery Chemistry, Therapeutics Discovery, Janssen Research and Development, LLC , 3210 Merryfield Row, La Jolla, CA 92121 , USA

Abstract

Abstract Damaged DNA-binding protein-1 (DDB1)- and CUL4-associated factor 12 (DCAF12) serves as the substrate recognition component within the Cullin4–RING E3 ligase (CRL4) complex, capable of identifying C-terminal double-glutamic acid degrons to promote the degradation of specific substrates through the ubiquitin proteasome system. Melanoma-associated antigen 3 (MAGEA3) and T-complex protein 1 subunit epsilon (CCT5) proteins have been identified as cellular targets of DCAF12. To further characterize the interactions between DCAF12 and both MAGEA3 and CCT5, we developed a suite of biophysical and proximity-based cellular NanoBRET assays showing that the C-terminal degron peptides of both MAGEA3 and CCT5 form nanomolar affinity interactions with DCAF12 in vitro and in cells. Furthermore, we report here the 3.17 Å cryo-EM structure of DDB1–DCAF12–MAGEA3 complex revealing the key DCAF12 residues responsible for C-terminal degron recognition and binding. Our study provides new insights and tools to enable the discovery of small molecule handles targeting the WD40-repeat domain of DCAF12 for future proteolysis targeting chimera design and development.

Funder

Bayer AG

Boehringer Ingelheim

Bristol Myers Squibb

Genentech

Ontario Genomics Institute

Innovative Medicines Initiative

Janssen

Merck KGaA

Pfizer

Takeda

Publisher

Oxford University Press (OUP)

Reference44 articles.

1. Targeted protein degradation: mechanisms, strategies and application;Zhao;Signal Transduct Target Ther,2022

2. The cullin protein family;Sarikas;Genome Biol,2011

3. Structural assembly of cullin-RING ubiquitin ligase complexes;Zimmerman;Curr Opin Struct Biol,2010

4. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase;Lee;Mol Cell,2007

5. Cul4 ubiquitin ligase cofactor DCAF12 promotes neurotransmitter release and homeostatic plasticity;Patrón;J Cell Biol,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3